Bayer Aktiengesellschaft (WSE:BAY)
Poland flag Poland · Delayed Price · Currency is PLN
117.04
+1.48 (1.28%)
Jul 16, 2025, 5:58 PM CET

Bayer Aktiengesellschaft Company Description

Bayer Aktiengesellschaft operates as a life science company worldwide.

The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products.

The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture.

It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing.

The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers.

Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Bayer Aktiengesellschaft
CountryGermany
Founded1863
IndustryDrug Manufacturers - General
SectorHealthcare
Employees91,864
CEOWilliam Anderson

Contact Details

Address:
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone49 214 30 1
Websitebayer.com

Stock Details

Ticker SymbolBAY
ExchangeWarsaw Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberDE000BAY0017
SIC Code2800

Key Executives

NamePosition
William AndersonChief Executive Officer
Wolfgang NicklChief Financial Officer
Sebastian GuthChief Operating Officer
Jost ReinhardHead of Investor Relations